ATRA NASDAQ · Healthcare · FY 2025-12-31
Atara Biotherapeutics, Inc.
ABV
EPV
EBV
DBV
fair value / share
buy at or below (margin of safety applied)
margin-of-safety band
current price
values in USD
Verdict
Unknown
Buy zone
Unknown
Archetype
Distressed/Deficit
Confidence
○○○
Insufficient · 0/4
Price
8.380 USD
Market cap
61.4M USD
P / B
-1.59
P / E
3.26
EPS
2.570
DPS / yield
— (0.0%)
NAV / share
-5.257
Graham number
—
Z'' score
-315.18
Piotroski F
4 / 9
Beneish M
17.01
ROIC vs WACC
—
vs 9.6%
See the full orchestrator pipeline — solvency gate, lens cascade, reconciliation, archetype, decision, and confidence.
Subscribe to unlock this and every other tab for every company.
See the full ABV lens breakdown — gates, steps, and verdict.
Subscribe to unlock this and every other tab for every company.
See the full EPV lens breakdown — gates, steps, and verdict.
Subscribe to unlock this and every other tab for every company.
See the full EBV lens breakdown — gates, steps, and verdict.
Subscribe to unlock this and every other tab for every company.
See the full DBV lens breakdown — gates, steps, and verdict.
Subscribe to unlock this and every other tab for every company.